Geriatric patients frequently are cared for in long term care facilities (LTCFs) which
are now a major component of our health care delivery system. These facilities provide
a range of necessary services including rehabilitation, chronic care, adult daycare,
assisted living, and skilled nursing. At present, approximately 2.5 million residents
live in LTCFs. Nearly half of the 2.2 million people who turned 65 years old in 1990
will enter an LTCFs at least once before they die [
1
,
2
].To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Infectious disease in the aging.Humana Press, Totowa, NJ2000
- Lifetime use of nursing home care.N Engl J Med. 1991; 324: 595-600
- Causes for hospitalization of nursing home residents: the role of infection.J Am Geriatr Soc. 1984; 32: 103-107
- Antecedents of death in the men of a Veterans Administration nursing home.J Am Geriatr Soc. 1987; 35: 496-502
- Infections and antibiotic resistance in nursing homes.Clin Microbiol Rev. 1996; 9: 1-17
- Infection and infection control in long term care settings.in: Yoshikawa T.T Norman D.C Infectious disease in the aging. Humana Press, Totowa, NJ2000
- Infection control in long-term-care facilities.Infect Control Hosp Epidemiol. 1995; 16: 348-353
- Infections and infection control among residents of eight rural Wisconsin nursing homes.Arch Intern Med. 1986; 146: 1981-1984
- Prevalence survey of infections and their predisposing factors at a hospital-based nursing home care unit.J Am Geriatr Soc. 1986; 34: 95-100
- Two years of infection surveillance in a geriatric long-term care facility.Am J Infect Control. 1991; 19: 185-190
Hing E. Effects of prospective payment system on nursing homes. Vital and Health Statistics, Series 13. Data from the National Health Survey. 1989;102:1–8613.
- Validation and application of the pneumonia prognosis index to nursing home residents with pneumonia.J Am Geriatr Soc. 1998; 46: 1538-1544
- Antibiotic resistance in long-term care facilities.Infect Control Hosp Epidemiol. 1991; 12: 245-250
- Resistant bacteria and infection control in the nursing home and hospital.Bull NY Acad Med. 1987; 63: 337-344
- Colonization and infection with antibiotic-resistant bacteria in a long-term care facility.J Am Geriatr Soc. 1994; 42: 1062-1069
- VRE, MRSA, PRP, and DRGNB in LTCF: lessons to be learned from this alphabet.J Am Geriatr Soc. 1998; 46: 241-243
- Issues in the management of resistant bacteria in long-term-care facilities.Infect Control Hosp Epidemiol. 1999; 20: 362-366
- Antibiotic resistance: why is it increasing in nursing homes?.Geriatrics. 1997; 52 (39–43): 34-36
- Interaction between antimicrobial consumption and selection of resistant bacterial strains.Scand J Infect Dis Suppl. 1990; 70: 18-24
- Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics.Clin Infect Dis. 1997; 24: S19-S45
- beta-Lactamases in laboratory and clinical resistance.Clin Microbiol Rev. 1995; 8: 557-584
- The structure of beta-lactamases.Philos Trans R Soc Lond B Biol Sci. 1980; 289: 321-331
- A functional classification scheme for beta-lactamases and its correlation with molecular structure.Antimicrob Agents Chemother. 1995; 39: 1211-1233
- Carbapenem-hydrolyzing beta-lactamases.Antimicrob Agents Chemother. 1997; 41: 223-232
- ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of beta-lactamases of the penicillinase type.Proc Natl Acad Sci USA. 1981; 78: 4897-4901
- Precise insertion of antibiotic resistance determinants into Tn21-like transposons: nucleotide sequence of the OXA-1 beta-lactamase gene.Proc Natl Acad Sci USA. 1987; 84: 7378-7382
- A standard numbering scheme for the class A beta-lactamases.Biochem J. 1991; 276: 269-270
- Kinship and diversification of bacterial penicillin-binding proteins and beta-lactamases.Antimicrob Agents Chemother. 1998; 42: 1-17
- Extended-spectrum beta-lactamases.Antimicrob Agents Chemother. 1989; 33: 1131-1136
- More extended-spectrum beta-lactamases.Antimicrob Agents Chemother. 1991; 35: 1697-1704
- Genetics of extended-spectrum beta-lactamases.Eur J Clin Microbiol Infect Dis. 1994; 13: S2-S11
- Ultrahigh resolution structure of a class A beta-lactamase: on the mechanism and specificity of the extended-spectrum SHV-2 enzyme.J Mol Biol. 2003; 328: 289-301
- Predicting the emergence of antibiotic resistance by directed evolution and structural analysis.Nat Struct Biol. 2001; 8: 238-242
- Trends in beta-lactam resistance among Enterobacteriaceae.Clin Infect Dis. 1998; 27: S100-S106
- Cytosolic intermediates for cell wall biosynthesis and degradation control inducible beta-lactam resistance in gram-negative bacteria.Cell. 1997; 88: 823-832
- Three-dimensional structure of AmpC beta-lactamase from Escherichia coli bound to a transition-state analogue: possible implications for the oxyanion hypothesis and for inhibitor design.Biochemistry. 1998; 37: 16082-16092
- Evolution of an enzyme activity: crystallographic structure at 2-A resolution of cephalosporinase from the ampC gene of Enterobacter cloacae P99 and comparison with a class A penicillinase.Proc Natl Acad Sci USA. 1993; 90: 11257-11261
- Chromosomally encoded ampC-type beta-lactamase in a clinical isolate of Proteus mirabilis.Antimicrob Agents Chemother. 1998; 42: 1110-1114
- A novel type of AmpC beta-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia.Antimicrob Agents Chemother. 1999; 43: 1924-1931
- Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 beta-lactamase production and loss of an outer membrane protein.Antimicrob Agents Chemother. 1999; 43: 1206-1210
- Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae.Antimicrob Agents Chemother. 1999; 43: 1669-1673
- Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.Antimicrob Agents Chemother. 1997; 41: 563-569
- Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae.Antimicrob Agents Chemother. 1990; 34: 2200-2209
- Nucleotide sequence of a plasmid-mediated cephalosporinase gene (blaLAT-1) found in Klebsiella pneumoniae.Antimicrob Agents Chemother. 1994; 38: 2207-2209
- Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae.Antimicrob Agents Chemother. 2000; 44: 622-632
- IBC-1, a novel integron-associated class A beta-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain.Antimicrob Agents Chemother. 2000; 44: 2247-2253
- New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy.Clin Infect Dis. 2001; 32: 1085-1089
- Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A beta-lactamase isolated from Escherichia coli.Antimicrob Agents Chemother. 1995; 39: 2269-2275
- Transferable production of PER-1 beta-lactamase in Pseudomonas aeruginosa.J Antimicrob Chemother. 1995; 35: 281-294
- Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.Infection. 1983; 11: 315-317
- Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods.J Clin Microbiol. 2001; 39: 2864-2872
- Clinical strategies for serious infection: a North American perspective.Diagn Microbiol Infect Dis. 1998; 31: 389-395
- Antimicrobial resistance in intensive care units.Clin Chest Med. 1999; 20 ([viii]): 303-316
- Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database–USA.Clin Infect Dis. 1999; 29: 259-263
- International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections.Ann Intern Med. 2004; 140: 26-32
- Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamases.Antimicrob Agents Chemother. 2003; 47: 3554-3560
- Methods for dilution antimicrobial susceptibility tests for bacteria the grow aerobically: approved standards.6th edition. National Committee for Clinical Laboratory Standards, Wayne (PA)2003 (M7–A6)
- Quality of antimicrobial susceptibility testing in the UK: a Pseudomonas aeruginosa survey revisited.J Antimicrob Chemother. 1999; 43: 517-522
- Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli.J Clin Microbiol. 1996; 34: 908-911
- Mutations altering substrate specificity in OHIO-1, and SHV-1 family beta-lactamase.Biochem J. 1992; 284: 411-415
- Dissemination in five French hospitals of Klebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam.Eur J Clin Microbiol Infect Dis. 1988; 7: 780-782
- Comparative study of a novel plasmid-mediated beta-lactamase, CAZ-2, and the CTX-1 and CAZ-1 enzymes conferring resistance to broad-spectrum cephalosporins.Antimicrob Agents Chemother. 1988; 32: 1660-1665
- SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams.Antimicrob Agents Chemother. 1989; 33: 951-956
- Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility.Antimicrob Agents Chemother. 1990; 34: 2193-2199
- SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients.Antimicrob Agents Chemother. 1995; 39: 899-905
- Multiply antibiotic-resistant gram-negative bacilli in a long-term-care facility: a case-control study of patient risk factors and prior antibiotic use.Infect Control Hosp Epidemiol. 1997; 18: 809-813
- Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation.J Infect Dis. 1996; 174: 529-536
- Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy.J Infect Dis. 1996; 173: 151-158
- Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center.Clin Infect Dis. 1996; 23: 118-124
- Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.JAMA. 1999; 281: 517-523
- Beta-lactam resistance in normal faecal flora from South Africa.Epidemiol Infect. 1995; 115: 243-253
- Epidemiology and control of nosocomial infections in adult intensive care units.Am J Med. 1991; 91: 179S-184S
- High frequency of antimicrobial resistance in human fecal flora.Antimicrob Agents Chemother. 1988; 32: 1801-1806
- Colonization of resistant faecal aerobic gram-negative bacilli among geriatric patients in hospital and the community.J Antimicrob Chemother. 1996; 37: 169-173
- Problem of antimicrobial resistance of fecal aerobic gram-negative bacilli in the elderly.Antimicrob Agents Chemother. 1996; 40: 2399-2403
- Cefotaxime-resistant bacteria colonizing older people admitted to an acute care hospital.J Am Geriatr Soc. 2003; 51: 519-522
- The use of analytical isoelectric focusing for detection and identification of beta-lactamases.J Gen Microbiol. 1975; 88: 169-178
- Comparison of polyacrylamide and agarose gel thin-layer isoelectric focusing for the characterization of beta-lactamases.Antimicrob Agents Chemother. 1983; 24: 186-189
- Rapid method of extraction and analysis of extended-spectrum beta-lactamases from clinical strains of Klebsiella pneumoniae.Clin Microbiol Infect. 2001; 7: 709-711
- Discrimination of SHV beta-lactamase genes by restriction site insertion-PCR.Antimicrob Agents Chemother. 2001; 45: 2110-2114
- Rapid discriminatory detection of genes coding for SHV beta-lactamases by ligase chain reaction.Antimicrob Agents Chemother. 2000; 44: 1860-1864
- Real-time PCR and melting curve analysis for reliable and rapid detection of SHV extended-spectrum beta-lactamases.Antimicrob Agents Chemother. 2001; 45: 1730-1736
- Application of pulsed field gel electrophoresis to molecular epidemiology. Diagnostic molecular epidemiology.American Society for Microbiology, Washington, DC1993 (563–72)
- Development of a sensitive and specific enzyme-linked immunosorbent assay for detecting and quantifying CMY-2 and SHV beta-lactamases.J Clin Microbiol. 2002; 40: 1947-1957
- Resolution of recent evolutionary divergence among Escherichia coli from related lineages: the application of pulsed field electrophoresis to molecular epidemiology.J Infect Dis. 1990; 161: 230-235
- Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites.J Clin Microbiol. 1990; 28: 2059-2063
- DNA fingerprinting by pulsed-field gel electrophoresis is more effective than ribotyping in distinguishing among methicillin-resistant Staphylococcus aureus isolates.J Clin Microbiol. 1992; 30: 967-973
- Rapid preparation of bacterial DNA for pulsed-field gel electrophoresis.J Clin Microbiol. 1996; 34: 2598-2600
- Surveillance, reporting and the use of computers.in: Wenzel R.D Prevention and control of nosocomial infections. Williams and Wilkins, Baltimore (MD)1993
Article info
Footnotes
☆This work was supported by grants from the Veterans Affairs Medical Center Merit Review Program.
Identification
Copyright
© 2004 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
